{
 "ticker": "IHI",
 "name": "iShares U.S. Medical Devices ETF",
 "issuer": "iShares",
 "desk": "themes",
 "url": "https://etfiq.com/funds/IHI",
 "html": "https://etfiq.com/funds/IHI",
 "markdown": "https://etfiq.com/funds/IHI.md",
 "as_of": "2026-09-11",
 "verdict": "IHI holds 48 stocks, and 12% of its weight is outside the S&P 500.",
 "key_facts": [
  {
   "key": "already_in_the_s_p_500",
   "label": "Already in the S&P 500",
   "value": "87.5%",
   "source": null,
   "as_of": "2026-09-11",
   "sentence": "IHI, already in the S&P 500: 87.5%, as of Sep 11, 2026."
  },
  {
   "key": "active_share_vs_the_s_p_500",
   "label": "Active share vs the S&P 500",
   "value": "98.7%",
   "source": null,
   "as_of": "2026-09-11",
   "sentence": "IHI, active share vs the S&P 500: 98.7%, as of Sep 11, 2026."
  },
  {
   "key": "top_ten_holdings",
   "label": "Top ten holdings",
   "value": "74.5%",
   "source": null,
   "as_of": "2026-09-11",
   "sentence": "IHI, top ten holdings: 74.5%, as of Sep 11, 2026."
  },
  {
   "key": "total_return_1_year",
   "label": "Total return, 1 year",
   "value": "\u221217.3%",
   "source": null,
   "as_of": "2026-09-11",
   "sentence": "IHI, total return, 1 year: \u221217.3%, as of Sep 11, 2026."
  },
  {
   "key": "net_assets",
   "label": "Net assets",
   "value": "$3.0bn",
   "source": "SEC filing, whole fund, as filed for Jun 30, 2026",
   "as_of": "2026-09-11",
   "sentence": "IHI, net assets: $3.0bn (SEC filing, whole fund, as filed for Jun 30, 2026)."
  },
  {
   "key": "expense_ratio",
   "label": "Expense ratio",
   "value": "0.37%",
   "source": "485BPOS XBRL, Jul 27, 2026",
   "as_of": "2026-09-11",
   "sentence": "IHI, expense ratio: 0.37% (485BPOS XBRL, Jul 27, 2026)."
  }
 ],
 "fields": [
  {
   "key": "theme",
   "label": "Theme",
   "value": "Therapeutics and medical devices",
   "source": "ETFIQ, editorial"
  },
  {
   "key": "launched",
   "label": "Launched",
   "value": "Jan 4, 2010",
   "source": null
  },
  {
   "key": "already_in_the_s_p_500_by_weight",
   "label": "Already in the S&P 500, by weight",
   "value": "87.5%",
   "source": "ETFIQ"
  },
  {
   "key": "active_share_vs_the_s_p_500",
   "label": "Active share vs the S&P 500",
   "value": "98.7%",
   "source": "ETFIQ"
  },
  {
   "key": "already_in_the_nasdaq_100_by_weight",
   "label": "Already in the Nasdaq-100, by weight",
   "value": "26.6%",
   "source": "ETFIQ"
  },
  {
   "key": "active_share_vs_the_nasdaq_100",
   "label": "Active share vs the Nasdaq-100",
   "value": "98.9%",
   "source": "ETFIQ"
  },
  {
   "key": "top_ten_holdings_weight",
   "label": "Top ten holdings weight",
   "value": "74.5%",
   "source": null
  },
  {
   "key": "holdings",
   "label": "Holdings",
   "value": "48",
   "source": null
  },
  {
   "key": "holdings_as_of",
   "label": "Holdings as of",
   "value": "Sep 10, 2026",
   "source": "the issuer\u2019s daily file"
  },
  {
   "key": "top_holdings",
   "label": "Top holdings",
   "value": "ABBOTT LABORATORIES 18.8%, INTUITIVE SURGICAL 13.3%, STRYKER 9.7%, BECTON DICKINSON 5.2%, MEDTRONIC PLC 5.0%, DEXCOM INC 4.9%, RESMED 4.8%, EDWARDS LIFESCIENCES 4.4%, GE HEALTHCARE TECHNOLOGIES 4.4%, IDEXX LABORATORIES 4.0%",
   "source": null
  },
  {
   "key": "net_assets",
   "label": "Net assets",
   "value": "$3.0bn",
   "source": "SEC filing, whole fund, as filed for Jun 30, 2026"
  },
  {
   "key": "below_its_all_time_high",
   "label": "Below its all-time high",
   "value": "\u221222.5%",
   "source": "ETFIQ"
  },
  {
   "key": "expense_ratio",
   "label": "Expense ratio",
   "value": "0.37%",
   "source": "485BPOS XBRL, Jul 27, 2026"
  },
  {
   "key": "fee_for_the_part_that_differs_from_the_s_p_500_active_expense_ratio",
   "label": "Fee for the part that differs from the S&P 500, active expense ratio",
   "value": "0.37%",
   "source": "ETFIQ"
  },
  {
   "key": "closest_funds_by_holdings_overlap",
   "label": "Closest funds by holdings overlap",
   "value": "MDEV 31%, HEAL 20%, EKG 19%, HTEC 17%, AGNG 17%",
   "source": null
  }
 ],
 "periods": [
  {
   "window": "3 months",
   "Total return": "+2.6%",
   "S&P 500": "+3.3%",
   "Gap to S&P 500": "\u22120.7 pts",
   "Gap to Nasdaq-100": "+3.4 pts"
  },
  {
   "window": "6 months",
   "Total return": "\u22126.7%",
   "S&P 500": "+16.0%",
   "Gap to S&P 500": "\u221222.7 pts",
   "Gap to Nasdaq-100": "\u221227.4 pts"
  },
  {
   "window": "1 year",
   "Total return": "\u221217.3%",
   "S&P 500": "+17.5%",
   "Gap to S&P 500": "\u221234.8 pts",
   "Gap to Nasdaq-100": "\u221240.3 pts"
  },
  {
   "window": "3 years",
   "Total return": "+1.7%",
   "S&P 500": "+77.9%",
   "Gap to S&P 500": "\u221276.2 pts",
   "Gap to Nasdaq-100": "\u221293.4 pts"
  },
  {
   "window": "Since launch",
   "Total return": "+515.4%",
   "S&P 500": "+804.4%",
   "Gap to S&P 500": "\u2212289.0 pts",
   "Gap to Nasdaq-100": "\u22121158.5 pts"
  }
 ],
 "questions": [
  {
   "q": "How much of IHI is in S&P 500 companies?",
   "a": "By its holdings published by its issuer for Sep 10, 2026, 88% of IHI by weight is stocks the S&P 500 already holds. Its active share against the index is 99%, so that share is the part doing something different."
  },
  {
   "q": "What does IHI hold?",
   "a": "48 positions as published by its issuer for Sep 10, 2026, with the top ten at 74% of the fund. The largest are ABBOTT LABORATORIES at 18.8%, INTUITIVE SURGICAL at 13.3%, STRYKER at 9.7%."
  },
  {
   "q": "Has IHI beaten the S&P 500?",
   "a": "Over the year to Sep 11, 2026 IHI returned \u221217.3% with distributions reinvested, against +17.5% for the S&P 500, so it finished behind the index by 34.8 points."
  },
  {
   "q": "What does IHI cost?",
   "a": "The prospectus expense ratio is 0.37% a year. Because 99% of the fund differs from the S&P 500, the fee on that differing part works out at 0.37%."
  }
 ],
 "generated": "2026-09-13",
 "license": "Free to use with attribution. ETFIQ (etfiq.com)."
}